Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Express Scripts
Chinese Patent Office
Julphar
AstraZeneca
Chubb
Dow
Citi
QuintilesIMS
Merck

Generated: February 18, 2018

DrugPatentWatch Database Preview

AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Aminosyn Ii 4.25% M In Dextrose 10% In Plastic Container patents expire, and what generic alternatives are available?

Aminosyn Ii 4.25% M In Dextrose 10% In Plastic Container is a drug marketed by Abbott and Hospira Inc and is included in two NDAs.

The generic ingredient in AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER is amino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate. There are three hundred and forty-five drug master file entries for this compound. Additional details are available on the amino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate profile page.
Summary for AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER
Drug patent expirations by year for AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER

US Patents and Regulatory Information for AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER amino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate INJECTABLE;INJECTION 019564-003 Dec 16, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira Inc AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER amino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate INJECTABLE;INJECTION 019682-002 Nov 1, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
UBS
QuintilesIMS
Argus Health
Express Scripts
Covington
Deloitte
Citi
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot